Search Results - "Ruiz, Nancy M."
-
1
Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults
Published in The New England journal of medicine (16-12-1999)“…The advent of new antiretroviral agents, most notably protease inhibitors, has generated new hope in the fight against human immunodeficiency virus type 1…”
Get full text
Journal Article -
2
Sustained clinical response as an endpoint in treatment trials of Clostridium difficile-associated diarrhea
Published in Antimicrobial agents and chemotherapy (01-08-2012)Get full text
Journal Article -
3
Therapy with Efavirenz plus Indinavir in Patients with Extensive Prior Nucleoside Reverse-Transcriptase Inhibitor Experience: A Randomized, Double-Blind, Placebo-Controlled Trial
Published in The Journal of infectious diseases (01-02-2001)“…A randomized, double-blind, placebo-controlled trial compared efavirenz (600 mg every 24 h) plus indinavir (1000 mg every 8 h) with placebo (every 24 h) plus…”
Get full text
Journal Article -
4
HIV type 1 genetic diversity in newly diagnosed Cuban patients
Published in AIDS research and human retroviruses (01-08-2012)“…Knowledge of the genetic diversity of HIV-1 constitutes a fundamental premise in the epidemiological surveillance. In the present study, the HIV-1 genetic…”
Get more information
Journal Article -
5
Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors in Children Infected with Human Immunodeficiency Virus Type 1
Published in The New England journal of medicine (16-12-1999)“…A major objective of antiretroviral therapy is to reduce the amount of human immunodeficiency virus type 1 (HIV-1) RNA in plasma to undetectable levels,…”
Get full text
Journal Article -
6
Patient-Reported Clinical Characteristics in a Randomized Controlled Trial in Seasonal Allergic Rhinitis (SAR)
Published in Journal of allergy and clinical immunology (01-02-2015)“…In a clinical trial of azelastine HCL/fluticasone propionate (AZ/FP) nasal spray (Dymista) in patients with SAR, a rhinitis questionnaire1 was used to identify…”
Get full text
Journal Article -
7
Efficacy and Safety of Flunisolide HFA (Aerospan) in Asthma Across Various Subgroups
Published in Chest (01-10-2014)Get full text
Journal Article -
8
Evaluation of Efficacy of Flunisolide HFA (AEROSPAN) in Children 4 to 11 Years of Age: A Sub-Group Efficacy Analysis By Baseline Asthma Medication Use
Published in Journal of allergy and clinical immunology (01-02-2015)“…Rationale A 12-week, multicenter, placebo- and active-controlled trial in pediatric patients 4 to 11 years (n=513) with mild-to-moderate asthma was conducted,…”
Get full text
Journal Article -
9
Efficacy of Azelastine HCl/Fluticasone Propionate Nasal Spray in the Treatment of Nasal Congestion in Patients with Seasonal Allergic Rhinitis (SAR)
Published in Journal of allergy and clinical immunology (01-02-2015)“…The primary efficacy variable was change from baseline in the 12-hour reflective total nasal symptom score (rTNSS), which included nasal congestion, sneezing,…”
Get full text
Journal Article -
10
Quantification of the Distribution of Azelastine HCl/Fluticasone Propionate Nasal Spray in an Anatomical Model of the Human Nasal Cavity
Published in Journal of allergy and clinical immunology (01-02-2015)“…Rationale In vitro evaluations using an anatomical model of the human nasal cavity quantified the distribution of azelastine HCl (AZ) and fluticasone…”
Get full text
Journal Article -
11
Efavirenz in HIV Infection
Published in The New England journal of medicine (27-04-2000)“…To the Editor: Staszewski et al. (Dec. 16 issue) 1 report that “the combination of efavirenz, zidovudine, and lamivudine has greater antiviral activity . . …”
Get full text
Journal Article -
12
Procedimientos para la obtención de reactivos biológicos de los estuches DAVIH Ag P24 y DAVIH Ac P24
Published in Vaccimonitor (01-12-2003)“…La pandemia de SIDA es uno de los problemas actuales más graves que afectan a la humanidad. Como todavía no se cuenta con una vacuna efectiva a pesar de los…”
Get full text
Journal Article -
13
Procedimientos para la obtención de reactivos biológicos de los estuches DAVIH Ag P24 y DAVIH Ac P24
Published in Vaccimonitor (01-09-2003)“…La pandemia de SIDA es uno de los problemas actuales más graves que afectan a la humanidad. Como todavía no se cuenta con una vacuna efectiva a pesar de los…”
Get full text
Journal Article -
14
Quantitative Relationship of Circulating p24 Antigen with Human Immunodeficiency Virus (HIV) RNA and Specific Antibody in HIV-Infected Subjects Receiving Antiretroviral Therapy
Published in The Journal of infectious diseases (01-10-1995)“…To better understand the biologic meaning and potential clinical utility of p24 antigen measurements in human immunodeficiency virus (HIV) infection, p24…”
Get full text
Journal Article -
15
Characterization of HIV isolates arising after prolonged zidovudine therapy
Published in Journal of acquired immune deficiency syndromes (1988) (1992)“…Human immunodeficiency virus type 1 (HIV-1) was isolated from five patients with late-stage disease treated with zidovudine (ZDV) for more than 1 year…”
Get more information
Journal Article -
16
-
17
Relationship between Immune Complex-Dissociated p24 Antigen and Human Immunodeficiency Virus Type 1 RNA Titers in Plasma
Published in The Journal of infectious diseases (01-06-1996)“…Brown et al. recently analyzed immune complex-dissociated (ICD) p24 antigenemia and human immunodeficiency virus type 1 (HIV-1) RNA titers in a transverse…”
Get full text
Journal Article -
18
Determination of HIV-1 viral load on dried blood spot specimens
Published in Biotecnología Aplicada“…Dried blood spot specimens on filter paper were evaluated to determine the viral load of the human immunodeficiency virus type 1 (HIV-1), through the…”
Get full text
Journal Article -
19
Cutaneous reactions at the site of post-infection gp160 vaccination therapy in HIV-1+ patients
Published in International journal of dermatology (01-04-1998)“…Background Post‐infection vaccination with human immunodeficiency virus type 1 (HIV‐1) specific antigens has been hypothesized as a mechanism for generating a…”
Get full text
Journal Article